Ligence

Vilnius, Lithuania Founded: 2019 • Age: 7 yrs
AI-based 2D echocardiography is provided for heart ultrasound analysis.
Annual revenue - Latest available
Total funding $3.2M 2 rounds
Employees - Tracked headcount
Investors 7 Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Ligence

Ligence is a company based in Vilnius (Lithuania) founded in 2019. Ligence has raised $3.2 million across 2 funding rounds from investors including European Union, Simpact Ventures and CoInvest Capital. Ligence offers products and services including Ligence Heart and Integration Services. Ligence operates in a competitive market with competitors including iRhythm Tech, Ambra Health, Tricog, Ultromics and Evolucare, among others.

  • Headquarter Vilnius, Lithuania
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $3.2 M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.2 M (USD), Seed

    Nov 12, 2024

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ligence

Ligence offers a comprehensive portfolio of products and services, including Ligence Heart and Integration Services.

Product name locked
Category locked
Primary

AI tool for analyzing heart ultrasound images and generating reports.

Product name locked
Category locked
Locked

Services for connecting with PACS and EHR systems.

People of Ligence

Headcount 1-10
Employee Profiles 6
Employee Profiles
People
Neringa Valantinė
Project Manager
People
Arnas Karužas
Chief Executive Officer
People
Dovydas Matuliauskas
Business Development Manager
People
Gytautė Navikaitė
Research and Partnerships Manager

Unlock access to complete

Funding Insights of Ligence

Ligence has successfully raised a total of $3.2M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $3.2 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Ligence

Ligence has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include European Union, Simpact Ventures and CoInvest Capital.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
A venture capital fund focused on impact investing is operated.
Locked Locked Locked
-
Locked Locked Locked
Early stage tech investments are made by Lemonade Stand.
Locked Locked Locked
Premium access

Investor details for Ligence

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ligence

Investments
Premium access

Investment portfolio details for Ligence

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ligence

Premium access

Detailed financials for Ligence

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ligence Comparisons

Ligence Primary company
Description
AI-based 2D echocardiography is provided for heart ultrasoun...
Location
Vilnius, Lithuania
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Ligence

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ligence

Ligence operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, Ambra Health, Tricog, Ultromics and Evolucare, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
Locked Locked Locked
Cloud-based platform for medical image management and exchange
Locked Locked Locked
AI-powered cardiac diagnostic solutions are provided for care pathways.
Locked Locked Locked
AI-powered echocardiography analysis for cardiovascular disease detection is provided.
Locked Locked Locked
Software for critical care and medical imaging management is provided.
Locked Locked Locked
An analytics platform for managing hemodynamic instability is provided.
Premium access

Detailed competitors of Ligence

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ligence

Premium access

Complete news archive for Ligence

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ligence

Ligence was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Ligence is headquartered in Vilnius, Lithuania.

Ligence is a funded company, having raised a total of $3.2M across 2 funding rounds to date.

Ligence was founded in 2019 in Vilnius, Lithuania, within the healthcare sector. AI-based 2D echocardiography is offered by the company for automated analysis of cardiac ultrasounds. Real-time monitoring and prevention of heart disease are supported through this technology. Operations focus on integrating AI to assist in clinical heart assessments across medical settings.

Ligence's top competitors include Ambra Health, iRhythm Tech and Tricog.

Ligence offers Ligence Heart and Integration Services.

Ligence has 7 investors. Key investors include European Union, Simpact Ventures, CoInvest Capital, Lemonade Stand, and NGL.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available